Alumis Announces Proposed Public Offering of Common Stock
Alumis Announces Proposed Public Offering of Common Stock GlobeNewswire January 06, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced its plans to commence an underwritten public offering of $175.0 million of shares of […]